Texas Stock Exchange CEO: exchanges can build on Exxon’s retail model to rein in proxy advisors28 May 2026
Progress In Fight Against Malaria, As New Treatment Shows PromiseBy Press Room1 December 2025 A late stage trial for an investigational malaria drug called GanLum (ganaplacide/lumefantrine) has demonstrated a 97.4% cure rate, outperforming currently…